25.46 USD
-0.06 (-0.24%)
25.55 USD
+0.09 (+0.35%)
We assign a fundamental rating of 5 out of 10 to CCLDO. CCLDO was compared to 35 industry peers in the Health Care Technology industry. CCLDO has an average financial health and profitability rating. While showing a medium growth rate, CCLDO is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
CCLDO had positive earnings in the past year.
In the past year CCLDO had a positive cash flow from operations.
In the past 5 years CCLDO always reported negative net income.
CCLDO had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CCLDO has a Return On Assets of 2.63%. This is amongst the best in the industry. CCLDO outperforms 88.57% of its industry peers.
With an excellent Return On Equity value of 4.12%, CCLDO belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
CCLDO has a better Return On Invested Capital (13.98%) than 94.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.63% | ||
| ROE | 4.12% | ||
| ROIC | 13.98% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 2.08%, CCLDO is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
With an excellent Operating Margin value of 10.43%, CCLDO belongs to the best of the industry, outperforming 88.57% of the companies in the same industry.
CCLDO's Operating Margin has improved in the last couple of years.
The Gross Margin of CCLDO (46.49%) is worse than 74.29% of its industry peers.
In the last couple of years the Gross Margin of CCLDO has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.43% | ||
| PM (TTM) | 2.08% | ||
| GM | 46.49% |
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
2. Health
2.1 Basic Checks
CCLDO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CCLDO has more shares outstanding
The number of shares outstanding for CCLDO has been increased compared to 5 years ago.
Compared to 1 year ago, CCLDO has an improved debt to assets ratio.
2.2 Solvency
CCLDO has an Altman-Z score of 20.68. This indicates that CCLDO is financially healthy and has little risk of bankruptcy at the moment.
CCLDO has a better Altman-Z score (20.68) than 91.43% of its industry peers.
CCLDO has a debt to FCF ratio of 0.38. This is a very positive value and a sign of high solvency as it would only need 0.38 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 0.38, CCLDO is doing good in the industry, outperforming 74.29% of the companies in the same industry.
A Debt/Equity ratio of 0.12 indicates that CCLDO is not too dependend on debt financing.
CCLDO has a Debt to Equity ratio (0.12) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 0.38 | ||
| Altman-Z | 20.68 |
ROIC/WACC1.44
WACC9.73%
2.3 Liquidity
A Current Ratio of 1.26 indicates that CCLDO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.26, CCLDO is doing worse than 74.29% of the companies in the same industry.
A Quick Ratio of 1.15 indicates that CCLDO should not have too much problems paying its short term obligations.
The Quick ratio of CCLDO (1.15) is worse than 77.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.15 |
3. Growth
3.1 Past
CCLDO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.27%, which is quite impressive.
Looking at the last year, CCLDO shows a small growth in Revenue. The Revenue has grown by 2.97% in the last year.
CCLDO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.47% yearly.
EPS 1Y (TTM)107.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)2.97%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%8.83%
3.2 Future
The Earnings Per Share is expected to grow by 61.62% on average over the next years. This is a very strong growth
Based on estimates for the next years, CCLDO will show a quite strong growth in Revenue. The Revenue will grow by 9.34% on average per year.
EPS Next Y145.9%
EPS Next 2Y61.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2Y9.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 636.50, the valuation of CCLDO can be described as expensive.
Based on the Price/Earnings ratio, CCLDO is valued a bit cheaper than 65.71% of the companies in the same industry.
When comparing the Price/Earnings ratio of CCLDO to the average of the S&P500 Index (26.50), we can say CCLDO is valued expensively.
CCLDO is valuated quite expensively with a Price/Forward Earnings ratio of 208.01.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CCLDO is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CCLDO to the average of the S&P500 Index (23.93), we can say CCLDO is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 636.5 | ||
| Fwd PE | 208.01 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as CCLDO.
CCLDO's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 59.63 | ||
| EV/EBITDA | 41.19 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CCLDO has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CCLDO's earnings are expected to grow with 61.62% in the coming years.
PEG (NY)4.36
PEG (5Y)N/A
EPS Next 2Y61.62%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CCLDO has a Yearly Dividend Yield of 7.89%, which is a nice return.
CCLDO's Dividend Yield is rather good when compared to the industry average which is at 0.56. CCLDO pays more dividend than 97.14% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, CCLDO pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.89% |
5.2 History
The dividend of CCLDO is nicely growing with an annual growth rate of 21.20%!
CCLDO has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)21.2%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
The dividend of CCLDO is growing, but earnings are growing more, so the dividend growth is sustainable.
DPN/A
EPS Next 2Y61.62%
EPS Next 3YN/A
CARECLOUD INC - CCLD 8 3/4 PERP
NASDAQ:CCLDO (12/23/2025, 4:48:07 PM)
After market: 25.55 +0.09 (+0.35%)25.46
-0.06 (-0.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners21.27%
Inst Owner ChangeN/A
Ins Owners14.42%
Ins Owner ChangeN/A
Market Cap1.08B
Revenue(TTM)114.31M
Net Income(TTM)2.38M
Analysts80
Price Target46.12 (81.15%)
Short Float %0%
Short Ratio0.14
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.89% |
Yearly Dividend0.92
Dividend Growth(5Y)21.2%
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)63.4%
Min EPS beat(2)30.72%
Max EPS beat(2)96.08%
EPS beat(4)4
Avg EPS beat(4)62.09%
Min EPS beat(4)21.57%
Max EPS beat(4)100%
EPS beat(8)6
Avg EPS beat(8)6.7%
EPS beat(12)8
Avg EPS beat(12)0.7%
EPS beat(16)12
Avg EPS beat(16)12.54%
Revenue beat(2)1
Avg Revenue beat(2)2.58%
Min Revenue beat(2)-1.27%
Max Revenue beat(2)6.44%
Revenue beat(4)2
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-1.27%
Max Revenue beat(4)6.44%
Revenue beat(8)2
Avg Revenue beat(8)-0.78%
Revenue beat(12)2
Avg Revenue beat(12)-2.4%
Revenue beat(16)3
Avg Revenue beat(16)-2.05%
PT rev (1m)55.36%
PT rev (3m)66.32%
EPS NQ rev (1m)-12.5%
EPS NQ rev (3m)16.67%
EPS NY rev (1m)12.5%
EPS NY rev (3m)-12.9%
Revenue NQ rev (1m)-0.51%
Revenue NQ rev (3m)2.88%
Revenue NY rev (1m)1.54%
Revenue NY rev (3m)3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 636.5 | ||
| Fwd PE | 208.01 | ||
| P/S | 9.44 | ||
| P/FCF | 59.63 | ||
| P/OCF | 42.29 | ||
| P/B | 18.68 | ||
| P/tB | 175.93 | ||
| EV/EBITDA | 41.19 |
EPS(TTM)0.04
EY0.16%
EPS(NY)0.12
Fwd EY0.48%
FCF(TTM)0.43
FCFY1.68%
OCF(TTM)0.6
OCFY2.36%
SpS2.7
BVpS1.36
TBVpS0.14
PEG (NY)4.36
PEG (5Y)N/A
Graham Number1.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.63% | ||
| ROE | 4.12% | ||
| ROCE | 17.7% | ||
| ROIC | 13.98% | ||
| ROICexc | 14.93% | ||
| ROICexgc | 82.32% | ||
| OM | 10.43% | ||
| PM (TTM) | 2.08% | ||
| GM | 46.49% | ||
| FCFM | 15.84% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y52.71%
ROICexgc growth 5Y104.32%
ROICexc growth 3Y91.65%
ROICexc growth 5Y92.03%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
F-Score6
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 0.38 | ||
| Debt/EBITDA | 0.26 | ||
| Cap/Depr | 51.55% | ||
| Cap/Sales | 6.5% | ||
| Interest Coverage | 118.08 | ||
| Cash Conversion | 96.95% | ||
| Profit Quality | 760.91% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.15 | ||
| Altman-Z | 20.68 |
F-Score6
WACC9.73%
ROIC/WACC1.44
Cap/Depr(3y)74.91%
Cap/Depr(5y)76.9%
Cap/Sales(3y)8.36%
Cap/Sales(5y)8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y145.9%
EPS Next 2Y61.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.97%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%8.83%
Revenue Next Year6.69%
Revenue Next 2Y9.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y128.34%
EBIT growth 3Y47.96%
EBIT growth 5Y117.42%
EBIT Next Year219.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y212.1%
FCF growth 3Y68.43%
FCF growth 5Y21.21%
OCF growth 1Y43.66%
OCF growth 3Y15.69%
OCF growth 5Y22.06%
CARECLOUD INC - CCLD 8 3/4 PERP / CCLDO FAQ
What is the ChartMill fundamental rating of CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CCLDO.
Can you provide the valuation status for CARECLOUD INC - CCLD 8 3/4 PERP?
ChartMill assigns a valuation rating of 3 / 10 to CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO). This can be considered as Overvalued.
How profitable is CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) stock?
CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) has a profitability rating of 6 / 10.
Can you provide the financial health for CCLDO stock?
The financial health rating of CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) is 5 / 10.
What is the earnings growth outlook for CARECLOUD INC - CCLD 8 3/4 PERP?
The Earnings per Share (EPS) of CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) is expected to grow by 145.9% in the next year.